PALLA PHARMA LIMITED - Announcements

Currently unlisted. Add to my watchlist

Palla Pharma Limited is an Australia-based vertically integrated pharmaceutical company.... Palla Pharma Limited is an Australia-based vertically integrated pharmaceutical company. The Company's primary activities include production and distribution of Narcotic Raw Material (NRM), Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The Company operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The Company has developed a water-based extraction technology, which is used in NRM production. It operates in Victoria and Tasmania; and northern hemisphere operations based in Norway. It sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.More

NATURAL MEDICINE LEADERS

ASX-listed wellness consumer discretionary player Calmer Co (ASX:CCO) has revealed its e-commerce sales hit more than $10K per day in March.

Announcements

Filter Results

All Price Sensitive Only

PAL	Removal from Official List		02/08/22	86.22KB	Share
PAL	Update to Shareholders - Voluntary Delisting from ASX		26/07/22	235.75KB	Share
PAL	Update to Shareholders		21/06/22	138.99KB	Share
PAL	Update to Shareholders - Declaration of shares as worthless		09/06/22	140.58KB	Share
PAL	Update to Shareholders		23/05/22	143.19KB	Share
PAL	Update to shareholders		21/04/22	73.69KB	Share
PAL	Update to Shareholders		29/03/22	81.8KB	Share
PAL	Update to shareholders		09/03/22	87.38KB	Share
PAL	Update to shareholders		02/03/22	86.89KB	Share
PAL	Update to shareholders		16/02/22	96.58KB	Share
PAL	Update to Shareholders		27/01/22	99.92KB	Share
PAL	Update to Shareholders		20/01/22	226.57KB	Share
PAL	Update to shareholders		13/01/22	90.14KB	Share
PAL	Palla Pharma enters Voluntary Administration		17/12/21	96.26KB	Share
PAL	Voluntary Suspension	PRICE SENSITIVE	15/12/21	194.05KB	Share
PAL	Trading Halt	PRICE SENSITIVE	13/12/21	231.5KB	Share
PAL	Response to ASX Price Query	PRICE SENSITIVE	09/12/21	223.11KB	Share
PAL	Sale and Leaseback of Coolaroo Site	PRICE SENSITIVE	26/11/21	736KB	Share
PAL	Jobkeeper Payments Notice		08/11/21	408.03KB	Share
PAL	Resignation and appointment of Chief Financial Officer		05/10/21	99.44KB	Share
PAL	Investor Update Presentation Conference Call Recording		04/10/21	107.78KB	Share
PAL	Investor Update	PRICE SENSITIVE	30/09/21	1.63MB	Share
PAL	Interim Financial Report - 30 June 2021		30/09/21	630.72KB	Share
PAL	Half Year Results and Investor Update Conference Call		22/09/21	111.18KB	Share
PAL	Update on lodgement of reviewed half-year financial report		09/09/21	98.39KB	Share
PAL	Extension of Reporting Deadline for Interim Financial Report		01/09/21	98.96KB	Share
PAL	Appendix 4D & Preliminary Interim Report - 30 June 2021	PRICE SENSITIVE	31/08/21	284.66KB	Share
PAL	Revised Half Year Reporting Timetable & Results Presentation		30/08/21	108.25KB	Share
PAL	Half Year Results Presentation and Investor Conference Call		18/08/21	297.38KB	Share
PAL	European Co-Codamol submissions completed		23/06/21	383.47KB	Share
PAL	Appointment of Alloga widening UK distribution network		21/06/21	102.51KB	Share
PAL	Interactive recording and presentation of the 2021 AGM		27/05/21	280.48KB	Share
PAL	Results of Annual General Meeting		26/05/21	499.48KB	Share
PAL	2021 Annual General Meeting Presentation	PRICE SENSITIVE	26/05/21	2.17MB	Share
PAL	Palla Pharma Limited announces new CEO, Mr Giles Moss	PRICE SENSITIVE	26/05/21	362.01KB	Share
PAL	AGM to be held virtually due to COVID-19 restrictions		25/05/21	970.08KB	Share
PAL	PAL Formal Product Launch & Production Partnership Update	PRICE SENSITIVE	04/05/21	291.51KB	Share
PAL	Notice of Annual General Meeting/Proxy Form		19/04/21	2.37MB	Share
PAL	Change of Director's Interest Notice - I. Ross		13/04/21	249.32KB	Share
PAL	Change of Director's Interest Notice		31/03/21	254.33KB	Share
PAL	Change of Director's Interest Notice		31/03/21	519.25KB	Share
PAL	Appendix 2A		29/03/21	401.47KB	Share
PAL	Appendix 2A update		29/03/21	403.32KB	Share
PAL	Palla Pharma successfully completes Retail Entitlement Offer	PRICE SENSITIVE	25/03/21	304.23KB	Share
PAL	Palla Pharma 2020 Corporate Governance Statement		19/03/21	231.38KB	Share
PAL	Palla Pharma 2020 Appendix 4G		19/03/21	361.07KB	Share
PAL	Palla Pharma Annual Report		19/03/21	953.96KB	Share
PAL	First Palla Pharma 30/500 Co-Codamol Caplet Order	PRICE SENSITIVE	19/03/21	82.04KB	Share
PAL	Investor Update	PRICE SENSITIVE	17/03/21	119.85KB	Share
PAL	Retail Entitlement Offer Booklet	PRICE SENSITIVE	09/03/21	3.12MB	Share
PAL	Notice under section 708A(5)(e) of the Corporations Act 2001		08/03/21	321.63KB	Share
PAL	Appendix 2A update		05/03/21	403.23KB	Share
PAL	Appendix 2A		05/03/21	402.25KB	Share
PAL	Completion of Placement and Institutional Entitlement Offer	PRICE SENSITIVE	02/03/21	357.19KB	Share
PAL	FY20 Results & Capital Raising Presentation Call Recording		01/03/21	97.79KB	Share
PAL	Proposed issue of Securities - PAL		26/02/21	40.14KB	Share
PAL	Entitlement Offer	PRICE SENSITIVE	26/02/21	442.97KB	Share
PAL	Notice under section 708AA(2)(f) of the Corporations Act		26/02/21	633.08KB	Share
PAL	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	26/02/21	332.01KB	Share
PAL	FY20 Full Year Results & Capital Raising	PRICE SENSITIVE	26/02/21	2MB	Share
PAL	Trading Halt	PRICE SENSITIVE	26/02/21	362.95KB	Share
PAL	UK Marketing Authorisations Approval Granted	PRICE SENSITIVE	18/02/21	131.18KB	Share
PAL	Full Year Results Presentation and Investor Conference Call		12/02/21	469.68KB	Share
PAL	Final Director's Interest Notice		05/02/21	251.92KB	Share
PAL	Director Resignation		05/02/21	285.34KB	Share
PAL	Market Update - UK MAs, Current Trading and Business Review	PRICE SENSITIVE	01/02/21	113.2KB	Share
PAL	Final Director's Interest Notice		12/01/21	216.38KB	Share
PAL	Initial Director's Interest Notice		23/12/20	104.73KB	Share
PAL	Palla Pharma Appoints UK Based Non-Executive Director		23/12/20	58.04KB	Share
PAL	Resignation of Managing Director and Chief Executive Officer	PRICE SENSITIVE	22/12/20	99.68KB	Share
PAL	Marketing Authorisations Approval Process Update	PRICE SENSITIVE	03/12/20	99.11KB	Share
PAL	Investor Update	PRICE SENSITIVE	06/11/20	111.38KB	Share
PAL	Tasmania property sale	PRICE SENSITIVE	23/09/20	96.94KB	Share
PAL	HY Results Presentation and Investor Conf Call Recording		01/09/20	97.63KB	Share
PAL	1H20 Results Presentation	PRICE SENSITIVE	31/08/20	1.35MB	Share
PAL	1H20 Results Release Briefing	PRICE SENSITIVE	31/08/20	155.95KB	Share
PAL	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	31/08/20	529.53KB	Share
PAL	Half Year Results Presentation and Investor Conference Call		26/08/20	25.52KB	Share
PAL	FDF contract extension and marketing authorisation update	PRICE SENSITIVE	17/07/20	116.89KB	Share
PAL	Interactive recording and presentation of the 2020 AGM		03/06/20	95.76KB	Share
PAL	Results of Meeting		28/05/20	297.46KB	Share
PAL	2020 Annual General Meeting Presentation	PRICE SENSITIVE	28/05/20	1.46MB	Share
PAL	2020 AGM Chairman's Address	PRICE SENSITIVE	28/05/20	119.22KB	Share
PAL	Details of Registered Office		27/05/20	95.21KB	Share
PAL	Company Secretary Appointment/Resignation		27/05/20	95.43KB	Share
PAL	Palla Pharma UK Acquisition Update	PRICE SENSITIVE	26/05/20	150.2KB	Share
PAL	Palla Pharma 2020 AGM Update		19/05/20	562.51KB	Share
PAL	Palla Pharma Notice Of Meeting, Proxy Form & Annual Report		20/04/20	1.25MB	Share
PAL	Palla Pharma UK Acquisition Update	PRICE SENSITIVE	01/04/20	101.6KB	Share
PAL	Recording of Palla FY19 Financial Results Investor Briefing		28/02/20	99.33KB	Share
PAL	Palla Pharma Investor Presentation - FY19 Results & Outlook	PRICE SENSITIVE	27/02/20	1.21MB	Share
PAL	Palla Pharma 2019 Corporate Governance Statement		27/02/20	127.78KB	Share
PAL	Palla Pharma 2019 Appendix 4G		27/02/20	108.72KB	Share
PAL	Palla Pharma delivers double-digit growth in FY19	PRICE SENSITIVE	27/02/20	147.64KB	Share
PAL	Preliminary Final Report and Annual Report	PRICE SENSITIVE	27/02/20	797.86KB	Share
PAL	Timing of 2019FY Results Announcement & Investor Call		10/02/20	468.49KB	Share
PAL	Palla Pharma Investor Update	PRICE SENSITIVE	10/02/20	184.4KB	Share
PAL	Palla Pharma renegotiates debt facilities on improved terms	PRICE SENSITIVE	19/12/19	103.96KB	Share
PAL	Palla Pharma exits unprofitable CMO manufacturing agreement	PRICE SENSITIVE	18/12/19	125.3KB	Share
PAL	New CPO Supply Agreement & CPO Production Capacity Expansion	PRICE SENSITIVE	10/12/19	169.39KB	Share

PAL Removal from Official List
02/08/22		86.22KB	Share
PAL Update to Shareholders - Voluntary Delisting from ASX
26/07/22		235.75KB	Share
PAL Update to Shareholders
21/06/22		138.99KB	Share
PAL Update to Shareholders - Declaration of shares as worthless
09/06/22		140.58KB	Share
PAL Update to Shareholders
23/05/22		143.19KB	Share
PAL Update to shareholders
21/04/22		73.69KB	Share
PAL Update to Shareholders
29/03/22		81.8KB	Share
PAL Update to shareholders
09/03/22		87.38KB	Share
PAL Update to shareholders
02/03/22		86.89KB	Share
PAL Update to shareholders
16/02/22		96.58KB	Share
PAL Update to Shareholders
27/01/22		99.92KB	Share
PAL Update to Shareholders
20/01/22		226.57KB	Share
PAL Update to shareholders
13/01/22		90.14KB	Share
PAL Palla Pharma enters Voluntary Administration
17/12/21		96.26KB	Share
PAL Voluntary Suspension
15/12/21	PRICE SENSITIVE	194.05KB	Share
PAL Trading Halt
13/12/21	PRICE SENSITIVE	231.5KB	Share
PAL Response to ASX Price Query
09/12/21	PRICE SENSITIVE	223.11KB	Share
PAL Sale and Leaseback of Coolaroo Site
26/11/21	PRICE SENSITIVE	736KB	Share
PAL Jobkeeper Payments Notice
08/11/21		408.03KB	Share
PAL Resignation and appointment of Chief Financial Officer
05/10/21		99.44KB	Share
PAL Investor Update Presentation Conference Call Recording
04/10/21		107.78KB	Share
PAL Investor Update
30/09/21	PRICE SENSITIVE	1.63MB	Share
PAL Interim Financial Report - 30 June 2021
30/09/21		630.72KB	Share
PAL Half Year Results and Investor Update Conference Call
22/09/21		111.18KB	Share
PAL Update on lodgement of reviewed half-year financial report
09/09/21		98.39KB	Share
PAL Extension of Reporting Deadline for Interim Financial Report
01/09/21		98.96KB	Share
PAL Appendix 4D & Preliminary Interim Report - 30 June 2021
31/08/21	PRICE SENSITIVE	284.66KB	Share
PAL Revised Half Year Reporting Timetable & Results Presentation
30/08/21		108.25KB	Share
PAL Half Year Results Presentation and Investor Conference Call
18/08/21		297.38KB	Share
PAL European Co-Codamol submissions completed
23/06/21		383.47KB	Share
PAL Appointment of Alloga widening UK distribution network
21/06/21		102.51KB	Share
PAL Interactive recording and presentation of the 2021 AGM
27/05/21		280.48KB	Share
PAL Results of Annual General Meeting
26/05/21		499.48KB	Share
PAL 2021 Annual General Meeting Presentation
26/05/21	PRICE SENSITIVE	2.17MB	Share
PAL Palla Pharma Limited announces new CEO, Mr Giles Moss
26/05/21	PRICE SENSITIVE	362.01KB	Share
PAL AGM to be held virtually due to COVID-19 restrictions
25/05/21		970.08KB	Share
PAL PAL Formal Product Launch & Production Partnership Update
04/05/21	PRICE SENSITIVE	291.51KB	Share
PAL Notice of Annual General Meeting/Proxy Form
19/04/21		2.37MB	Share
PAL Change of Director's Interest Notice - I. Ross
13/04/21		249.32KB	Share
PAL Change of Director's Interest Notice
31/03/21		254.33KB	Share
PAL Change of Director's Interest Notice
31/03/21		519.25KB	Share
PAL Appendix 2A
29/03/21		401.47KB	Share
PAL Appendix 2A update
29/03/21		403.32KB	Share
PAL Palla Pharma successfully completes Retail Entitlement Offer
25/03/21	PRICE SENSITIVE	304.23KB	Share
PAL Palla Pharma 2020 Corporate Governance Statement
19/03/21		231.38KB	Share
PAL Palla Pharma 2020 Appendix 4G
19/03/21		361.07KB	Share
PAL Palla Pharma Annual Report
19/03/21		953.96KB	Share
PAL First Palla Pharma 30/500 Co-Codamol Caplet Order
19/03/21	PRICE SENSITIVE	82.04KB	Share
PAL Investor Update
17/03/21	PRICE SENSITIVE	119.85KB	Share
PAL Retail Entitlement Offer Booklet
09/03/21	PRICE SENSITIVE	3.12MB	Share
PAL Notice under section 708A(5)(e) of the Corporations Act 2001
08/03/21		321.63KB	Share
PAL Appendix 2A update
05/03/21		403.23KB	Share
PAL Appendix 2A
05/03/21		402.25KB	Share
PAL Completion of Placement and Institutional Entitlement Offer
02/03/21	PRICE SENSITIVE	357.19KB	Share
PAL FY20 Results & Capital Raising Presentation Call Recording
01/03/21		97.79KB	Share
PAL Proposed issue of Securities - PAL
26/02/21		40.14KB	Share
PAL Entitlement Offer
26/02/21	PRICE SENSITIVE	442.97KB	Share
PAL Notice under section 708AA(2)(f) of the Corporations Act
26/02/21		633.08KB	Share
PAL Appendix 4E - Preliminary Final Report
26/02/21	PRICE SENSITIVE	332.01KB	Share
PAL FY20 Full Year Results & Capital Raising
26/02/21	PRICE SENSITIVE	2MB	Share
PAL Trading Halt
26/02/21	PRICE SENSITIVE	362.95KB	Share
PAL UK Marketing Authorisations Approval Granted
18/02/21	PRICE SENSITIVE	131.18KB	Share
PAL Full Year Results Presentation and Investor Conference Call
12/02/21		469.68KB	Share
PAL Final Director's Interest Notice
05/02/21		251.92KB	Share
PAL Director Resignation
05/02/21		285.34KB	Share
PAL Market Update - UK MAs, Current Trading and Business Review
01/02/21	PRICE SENSITIVE	113.2KB	Share
PAL Final Director's Interest Notice
12/01/21		216.38KB	Share
PAL Initial Director's Interest Notice
23/12/20		104.73KB	Share
PAL Palla Pharma Appoints UK Based Non-Executive Director
23/12/20		58.04KB	Share
PAL Resignation of Managing Director and Chief Executive Officer
22/12/20	PRICE SENSITIVE	99.68KB	Share
PAL Marketing Authorisations Approval Process Update
03/12/20	PRICE SENSITIVE	99.11KB	Share
PAL Investor Update
06/11/20	PRICE SENSITIVE	111.38KB	Share
PAL Tasmania property sale
23/09/20	PRICE SENSITIVE	96.94KB	Share
PAL HY Results Presentation and Investor Conf Call Recording
01/09/20		97.63KB	Share
PAL 1H20 Results Presentation
31/08/20	PRICE SENSITIVE	1.35MB	Share
PAL 1H20 Results Release Briefing
31/08/20	PRICE SENSITIVE	155.95KB	Share
PAL Appendix 4D and Half Year Financial Report
31/08/20	PRICE SENSITIVE	529.53KB	Share
PAL Half Year Results Presentation and Investor Conference Call
26/08/20		25.52KB	Share
PAL FDF contract extension and marketing authorisation update
17/07/20	PRICE SENSITIVE	116.89KB	Share
PAL Interactive recording and presentation of the 2020 AGM
03/06/20		95.76KB	Share
PAL Results of Meeting
28/05/20		297.46KB	Share
PAL 2020 Annual General Meeting Presentation
28/05/20	PRICE SENSITIVE	1.46MB	Share
PAL 2020 AGM Chairman's Address
28/05/20	PRICE SENSITIVE	119.22KB	Share
PAL Details of Registered Office
27/05/20		95.21KB	Share
PAL Company Secretary Appointment/Resignation
27/05/20		95.43KB	Share
PAL Palla Pharma UK Acquisition Update
26/05/20	PRICE SENSITIVE	150.2KB	Share
PAL Palla Pharma 2020 AGM Update
19/05/20		562.51KB	Share
PAL Palla Pharma Notice Of Meeting, Proxy Form & Annual Report
20/04/20		1.25MB	Share
PAL Palla Pharma UK Acquisition Update
01/04/20	PRICE SENSITIVE	101.6KB	Share
PAL Recording of Palla FY19 Financial Results Investor Briefing
28/02/20		99.33KB	Share
PAL Palla Pharma Investor Presentation - FY19 Results & Outlook
27/02/20	PRICE SENSITIVE	1.21MB	Share
PAL Palla Pharma 2019 Corporate Governance Statement
27/02/20		127.78KB	Share
PAL Palla Pharma 2019 Appendix 4G
27/02/20		108.72KB	Share
PAL Palla Pharma delivers double-digit growth in FY19
27/02/20	PRICE SENSITIVE	147.64KB	Share
PAL Preliminary Final Report and Annual Report
27/02/20	PRICE SENSITIVE	797.86KB	Share
PAL Timing of 2019FY Results Announcement & Investor Call
10/02/20		468.49KB	Share
PAL Palla Pharma Investor Update
10/02/20	PRICE SENSITIVE	184.4KB	Share
PAL Palla Pharma renegotiates debt facilities on improved terms
19/12/19	PRICE SENSITIVE	103.96KB	Share
PAL Palla Pharma exits unprofitable CMO manufacturing agreement
18/12/19	PRICE SENSITIVE	125.3KB	Share
PAL New CPO Supply Agreement & CPO Production Capacity Expansion
10/12/19	PRICE SENSITIVE	169.39KB	Share

REFRESH

1 2 3

PALLA PHARMA LIMITED - Announcements

Announcements

Top Stories